LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "treated ustekinumab" as a keyword



Photo from wikipedia

Japanese pediatric patient with moderately active ulcerative colitis successfully treated with ustekinumab

Sign Up to like & get
recommendations! Published in 2022 at "Medicine"

DOI: 10.1097/md.0000000000028873

Abstract: Abstract Rationale: Ustekinumab is effective in the treatment of adult Crohn disease (CD) and ulcerative colitis (UC). However, data on its efficacy and safety in pediatric CD and UC are limited. To the best of… read more here.

Keywords: moderately active; successfully treated; treated ustekinumab; colitis ... See more keywords
Photo by mykjohnson from unsplash

Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab

Sign Up to like & get
recommendations! Published in 2017 at "PLoS ONE"

DOI: 10.1371/journal.pone.0184178

Abstract: Background There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of… read more here.

Keywords: testing patients; qft; patients psoriasis; quantiferon gold ... See more keywords
Photo by ldxcreative from unsplash

Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review

Sign Up to like & get
recommendations! Published in 2023 at "Clinical, Cosmetic and Investigational Dermatology"

DOI: 10.2147/ccid.s404860

Abstract: Abstract Acrodermatitis continua of Hallopeau (ACH) is a rare variant of pustular psoriasis that presents as a sterile pustular eruption of the periungual and subungual regions. It affects the skin and nail bed and can… read more here.

Keywords: continua hallopeau; successfully treated; acrodermatitis continua; treated ustekinumab ... See more keywords
Photo from wikipedia

Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.

Sign Up to like & get
recommendations! Published in 2018 at "Acta dermato-venereologica"

DOI: 10.2340/00015555-2833

Abstract: Monitoring of biological treatment efficacy for psoriasis is based on clinical evaluation and patient's quality of life. However, long-term correlation between Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) in real… read more here.

Keywords: index; dermatology; correlation; treated ustekinumab ... See more keywords